- Home
- VALU vs SLP Comparison
VALU vs SLP Comparison
Compare VALU & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VALU | SLP |
|---|---|---|
| Founded | 1931 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.6M | 370.7M |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VALU | SLP |
|---|---|---|
| Price | $38.34 | $18.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 2.3K | ★ 178.7K |
| Earning Date | 03-16-2026 | 04-09-2026 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | ★ 4.55 | N/A |
| EPS | ★ 2.30 | 0.43 |
| Revenue | $36,257,000.00 | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ $16.30 | $42.77 |
| Revenue Growth | 1.08 | ★ 10.52 |
| 52 Week Low | $32.00 | $11.09 |
| 52 Week High | $41.18 | $21.01 |
Technical Indicators
Market Signals| Indicator | VALU | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 63.55 |
| Support Level | $36.26 | $18.22 |
| Resistance Level | $38.04 | $18.57 |
| Average True Range (ATR) | 1.40 | 0.04 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 37.41 | 88.00 |
Price Performance
Historical ComparisonAbout VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and makes available copyright data, including a ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets its products under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing, and The Most Trusted Name in Investment Research. Its only operating segment is Publishing.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.